marketcaparena
Search

    CAH

    CARDINAL HEALTH INC

    Company overview

    Market capitalization
    $51.23B
    Employees
    53,084
    Latest publication
    2026-09-29
    About CARDINAL HEALTH INC

    Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ4 20262026-06-30 · USDQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ4 20252025-06-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USD
    Total Revenue63,700,000,000USD60,940,000,000USD65,441,000,000USD64,009,000,000USD60,159,000,000USD54,878,000,000USD55,264,000,000USD52,277,000,000USD
    Selling General Administrative1,625,000,000USD1,542,000,000USD1,504,000,000USD1,461,000,000USD1,484,000,000USD1,315,000,000USD1,306,000,000USD1,277,000,000USD
    Income Before Tax554,000,000USD392,000,000USD630,000,000USD598,000,000USD384,000,000USD665,000,000USD511,000,000USD541,000,000USD
    Income Tax Expense154,000,000USD12,000,000USD159,000,000USD144,000,000USD141,000,000USD157,000,000USD110,000,000USD124,000,000USD
    Net Income398,000,000USD399,000,000USD471,000,000USD450,000,000USD239,000,000USD506,000,000USD400,000,000USD416,000,000USD
    Cost Of Revenue—58,442,000,000USD63,230,000,000USD61,690,000,000USD57,957,000,000USD52,755,000,000USD53,323,000,000USD50,375,000,000USD
    Gross Profit—2,498,000,000USD2,211,000,000USD2,319,000,000USD2,202,000,000USD2,123,000,000USD1,941,000,000USD1,902,000,000USD
    Unclassified Operating Expenses—447,000,000USD—190,000,000USD290,000,000USD78,000,000USD86,000,000USD57,000,000USD
    Total Operating Expenses—1,989,000,000USD1,504,000,000USD1,651,000,000USD1,774,000,000USD1,393,000,000USD1,392,000,000USD1,334,000,000USD
    Operating Income—509,000,000USD707,000,000USD668,000,000USD428,000,000USD730,000,000USD549,000,000USD568,000,000USD
    Interest Expense—101,000,000USD88,000,000USD80,000,000USD74,000,000USD74,000,000USD35,000,000USD32,000,000USD
    Net Interest Income—-101,000,000USD-88,000,000USD-80,000,000USD-74,000,000USD-74,000,000USD-35,000,000USD-32,000,000USD
    Tax Provision—12,000,000USD159,000,000USD144,000,000USD141,000,000USD157,000,000USD110,000,000USD124,000,000USD
    Net Income From Continuing Ops—380,000,000USD471,000,000USD454,000,000USD243,000,000USD508,000,000USD401,000,000USD417,000,000USD
    Ebit—509,000,000USD542,000,000USD678,000,000USD458,000,000USD739,000,000USD546,000,000USD573,000,000USD
    Ebitda—757,000,000USD707,000,000USD911,000,000USD667,000,000USD946,000,000USD738,000,000USD755,000,000USD
    Depreciation And Amortization—248,000,000USD165,000,000USD233,000,000USD209,000,000USD207,000,000USD192,000,000USD182,000,000USD
    Reconciled Depreciation—248,000,000USD234,000,000USD233,000,000USD209,000,000USD207,000,000USD192,000,000USD182,000,000USD
    Total Other Income Expense Net—-117,000,000USD-77,000,000USD-70,000,000USD-44,000,000USD-65,000,000USD-38,000,000USD-27,000,000USD
    Minority Interest—19,000,000USD-4,000,000USD-4,000,000USD-4,000,000USD-2,000,000USD-1,000,000USD-1,000,000USD
    Interest Income——88,000,000USD80,000,000USD74,000,000USD74,000,000USD35,000,000USD32,000,000USD
    Net Income Applicable To Common Shares——467,000,000USD450,000,000USD239,000,000USD506,000,000USD400,000,000USD416,000,000USD
    SourceDisclosurePreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20222022-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USD
    Total Revenue254,248,000,000USD222,578,000,000USD226,827,000,000USD204,979,000,000USD181,326,000,000USD162,467,000,000USD152,922,000,000USD145,534,000,000USD
    Cost Of Revenue244,474,000,000USD214,410,000,000USD219,413,000,000USD198,105,000,000USD174,842,000,000USD155,689,000,000USD146,054,000,000USD138,700,000,000USD
    Gross Profit9,774,000,000USD8,168,000,000USD7,414,000,000USD6,889,000,000USD6,484,000,000USD6,778,000,000USD6,868,000,000USD6,834,000,000USD
    Selling General Administrative6,132,000,000USD5,382,000,000USD5,000,000,000USD4,834,000,000USD4,557,000,000USD4,533,000,000USD4,572,000,000USD4,480,000,000USD
    Total Operating Expenses7,161,000,000USD5,893,000,000USD6,171,000,000USD6,122,000,000USD7,091,000,000USD6,306,000,000USD10,966,000,000USD4,774,000,000USD
    Operating Income2,613,000,000USD2,275,000,000USD1,243,000,000USD752,000,000USD-607,000,000USD472,000,000USD-4,098,000,000USD2,060,000,000USD
    Total Other Income Expense Net-439,000,000USD-174,000,000USD-42,000,000USD-89,000,000USD-177,000,000USD-149,000,000USD326,000,000USD-309,000,000USD
    Interest Expense348,000,000USD215,000,000USD51,000,000USD84,000,000USD147,000,000USD180,000,000USD238,000,000USD294,000,000USD
    Income Before Tax2,174,000,000USD2,101,000,000USD1,201,000,000USD663,000,000USD-784,000,000USD323,000,000USD-3,772,000,000USD1,751,000,000USD
    Income Tax Expense469,000,000USD532,000,000USD348,000,000USD332,000,000USD153,000,000USD-289,000,000USD-79,000,000USD386,000,000USD
    Net Income1,705,000,000USD1,561,000,000USD852,000,000USD330,000,000USD-938,000,000USD611,000,000USD-3,693,000,000USD1,363,000,000USD
    Minority Interest-9,000,000USD-8,000,000USD-1,000,000USD-1,000,000USD1,000,000USD3,000,000USD3,000,000USD2,000,000USD
    Net Income Applicable To Common Shares1,714,000,000USD1,561,000,000USD852,000,000USD261,000,000USD-933,000,000USD611,000,000USD-3,696,000,000USD1,363,000,000USD
    Unclassified Operating Expenses—511,000,000USD1,171,000,000USD1,288,000,000USD2,534,000,000USD1,773,000,000USD6,394,000,000USD294,000,000USD
    Interest Income—215,000,000USD51,000,000USD93,000,000USD147,000,000USD182,000,000USD341,000,000USD307,000,000USD
    Net Interest Income—-215,000,000USD-51,000,000USD-93,000,000USD-149,000,000USD-180,000,000USD-238,000,000USD-294,000,000USD
    Tax Provision—532,000,000USD348,000,000USD376,000,000USD163,000,000USD-289,000,000USD-79,000,000USD386,000,000USD
    Net Income From Continuing Ops—1,569,000,000USD853,000,000USD262,000,000USD-932,000,000USD612,000,000USD-3,693,000,000USD2,137,000,000USD
    Ebit—2,316,000,000USD1,252,000,000USD747,000,000USD-637,000,000USD503,000,000USD-3,534,000,000USD2,045,000,000USD
    Ebitda—3,106,000,000USD1,962,000,000USD1,439,000,000USD55,000,000USD1,286,000,000USD-2,621,000,000USD3,045,000,000USD
    Depreciation And Amortization—790,000,000USD710,000,000USD692,000,000USD692,000,000USD783,000,000USD913,000,000USD1,000,000,000USD
    Reconciled Depreciation—790,000,000USD710,000,000USD692,000,000USD692,000,000USD783,000,000USD913,000,000USD1,000,000,000USD
    Non Operating Income Net Other———4,000,000USD-24,000,000USD31,000,000USD-15,000,000USD-15,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ4 20262026-06-30 · USDQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ4 20252025-06-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USD
    Total Assets57,299,000,000USD56,689,000,000USD58,083,000,000USD55,228,000,000USD53,122,000,000USD49,871,000,000USD47,002,000,000USD43,059,000,000USD
    Cash And Equivalents4,856,000,000USD—2,777,000,000USD4,593,000,000USD3,874,000,000USD3,326,000,000USD3,810,000,000USD2,867,000,000USD
    Total Current Assets38,753,000,000USD38,064,000,000USD39,230,000,000USD38,537,000,000USD36,373,000,000USD34,595,000,000USD35,756,000,000USD32,905,000,000USD
    Other Current Assets2,764,000,000USD2,472,000,000USD2,675,000,000USD2,615,000,000USD2,426,000,000USD2,445,000,000USD2,673,000,000USD2,638,000,000USD
    Other Non Current Assets1,884,000,000USD———————
    Total Liabilities60,023,000,000USD———————
    Total Current Liabilities43,904,000,000USD41,989,000,000USD43,314,000,000USD40,268,000,000USD38,897,000,000USD36,662,000,000USD35,223,000,000USD34,678,000,000USD
    Total Stockholder Equity-2,883,000,000USD-2,832,000,000USD-2,700,000,000USD-2,879,000,000USD-2,781,000,000USD-2,948,000,000USD-2,991,000,000USD-3,277,000,000USD
    Total Equity Including Noncontrolling Interest-2,724,000,000USD———————
    Long Term Debt7,004,000,000USD8,245,000,000USD8,347,000,000USD8,980,000,000USD7,977,000,000USD7,136,000,000USD7,062,000,000USD4,224,000,000USD
    Inventory17,297,000,000USD18,007,000,000USD20,116,000,000USD17,559,000,000USD16,831,000,000USD16,158,000,000USD16,904,000,000USD15,619,000,000USD
    Property Plant Equipment Net4,022,000,000USD2,928,000,000USD2,877,000,000USD2,831,000,000USD2,858,000,000USD2,664,000,000USD2,558,000,000USD2,535,000,000USD
    Goodwill11,442,000,000USD———————
    Intangible Assets2,189,000,000USD2,283,000,000USD2,369,000,000USD2,399,000,000USD2,486,000,000USD2,108,000,000USD1,948,000,000USD1,663,000,000USD
    Accounts Payable38,283,000,000USD37,834,000,000USD38,996,000,000USD36,860,000,000USD34,713,000,000USD32,812,000,000USD31,298,000,000USD30,365,000,000USD
    Short Term Debt201,000,000USD671,000,000USD680,000,000USD52,000,000USD714,000,000USD543,000,000USD544,000,000USD940,000,000USD
    Common Stock2,887,000,000USD-7,218,000,000USD2,847,000,000USD2,746,000,000USD2,956,000,000USD2,946,000,000USD2,932,000,000USD2,827,000,000USD
    Retained Earnings2,009,000,000USD1,732,000,000USD1,455,000,000USD1,116,000,000USD783,000,000USD664,000,000USD283,000,000USD14,000,000USD
    Accumulated Other Comprehensive Income-165,000,000USD-161,000,000USD-153,000,000USD-159,000,000USD-155,000,000USD-176,000,000USD-180,000,000USD-155,000,000USD
    Total Liab—59,361,000,000USD60,783,000,000USD57,959,000,000USD55,756,000,000USD51,769,000,000USD49,923,000,000USD46,335,000,000USD
    Other Current Liab—3,484,000,000USD3,638,000,000USD3,356,000,000USD3,470,000,000USD3,307,000,000USD3,381,000,000USD3,373,000,000USD
    Capital Stock—2,815,000,000USD2,847,000,000USD2,746,000,000USD2,956,000,000USD2,946,000,000USD2,932,000,000USD2,827,000,000USD
    Good Will—13,698,000,000USD11,609,000,000USD9,711,000,000USD9,691,000,000USD8,906,000,000USD5,488,000,000USD4,725,000,000USD
    Cash—3,937,000,000USD2,777,000,000USD4,593,000,000USD3,874,000,000USD3,326,000,000USD3,810,000,000USD2,867,000,000USD
    Cash And Short Term Investments—3,937,000,000USD2,777,000,000USD4,593,000,000USD3,874,000,000USD3,326,000,000USD3,810,000,000USD2,867,000,000USD
    Net Debt—4,979,000,000USD6,250,000,000USD4,439,000,000USD5,471,000,000USD4,353,000,000USD3,796,000,000USD2,297,000,000USD
    Short Long Term Debt—671,000,000USD680,000,000USD52,000,000USD550,000,000USD543,000,000USD544,000,000USD940,000,000USD
    Short Long Term Debt Total—8,916,000,000USD9,027,000,000USD9,032,000,000USD9,345,000,000USD7,679,000,000USD7,606,000,000USD5,164,000,000USD
    Net Receivables—13,648,000,000USD13,662,000,000USD13,770,000,000USD13,242,000,000USD12,666,000,000USD12,369,000,000USD11,781,000,000USD
    Common Stock Shares Outstanding—236,000,000shares237,000,000shares239,000,000shares240,000,000shares241,000,000shares243,000,000shares245,000,000shares
    Non Current Assets Total—18,625,000,000USD18,853,000,000USD16,691,000,000USD16,749,000,000USD15,276,000,000USD11,246,000,000USD10,154,000,000USD
    Non Current Liabilities Total—17,532,000,000USD17,469,000,000USD17,839,000,000USD16,859,000,000USD15,107,000,000USD14,700,000,000USD11,657,000,000USD
    Non Current Liabilities Other—9,127,000,000USD9,122,000,000USD8,711,000,000USD8,882,000,000USD7,971,000,000USD7,638,000,000USD7,433,000,000USD
    Non Currrent Assets Other—1,999,000,000USD1,998,000,000USD1,750,000,000USD1,700,000,000USD1,451,000,000USD1,252,000,000USD1,231,000,000USD
    Net Working Capital—-3,925,000,000USD-4,084,000,000USD-1,731,000,000USD-2,524,000,000USD-2,067,000,000USD533,000,000USD-1,773,000,000USD
    Unclassified Non Current Assets—-2,283,000,000USD-1,998,000,000USD-1,750,000,000USD-1,700,000,000USD-1,451,000,000USD-1,252,000,000USD-1,231,000,000USD
    Unclassified Current Liabilities—-671,000,000USD-680,000,000USD—-550,000,000USD-543,000,000USD-544,000,000USD-940,000,000USD
    Other Assets——1,998,000,000USD1,750,000,000USD1,714,000,000USD1,598,000,000USD1,252,000,000USD1,231,000,000USD
    Unclassified Equity——-9,696,000,000USD-9,328,000,000USD-9,321,000,000USD-9,328,000,000USD-8,958,000,000USD-8,790,000,000USD
    Property Plant Equipment Gross————7,516,000,000USD———
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20222022-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USD
    Total Assets57,299,000,000USD53,122,000,000USD45,121,000,000USD43,349,000,000USD43,878,000,000USD44,453,000,000USD40,766,000,000USD40,963,000,000USD
    Cash And Equivalents4,856,000,000USD3,874,000,000USD5,133,000,000USD4,043,000,000USD4,717,000,000USD3,407,000,000USD2,771,000,000USD2,531,000,000USD
    Total Current Assets38,753,000,000USD36,373,000,000USD34,884,000,000USD33,737,000,000USD32,935,000,000USD31,048,000,000USD25,940,000,000USD25,747,000,000USD
    Other Current Assets2,764,000,000USD2,426,000,000USD2,710,000,000USD2,434,000,000USD2,021,000,000USD3,944,000,000USD1,707,000,000USD1,946,000,000USD
    Other Non Current Assets1,884,000,000USD———————
    Total Liabilities60,023,000,000USD———————
    Total Current Liabilities43,904,000,000USD38,897,000,000USD35,640,000,000USD33,740,000,000USD30,550,000,000USD27,624,000,000USD23,615,000,000USD24,109,000,000USD
    Total Stockholder Equity-2,883,000,000USD-2,781,000,000USD-3,213,000,000USD-2,958,000,000USD-709,000,000USD1,791,000,000USD1,789,000,000USD6,328,000,000USD
    Total Equity Including Noncontrolling Interest-2,724,000,000USD———————
    Long Term Debt7,004,000,000USD7,977,000,000USD4,658,000,000USD3,909,000,000USD4,735,000,000USD5,365,000,000USD6,740,000,000USD7,579,000,000USD
    Inventory17,297,000,000USD16,831,000,000USD14,957,000,000USD16,119,000,000USD15,636,000,000USD14,594,000,000USD13,198,000,000USD12,822,000,000USD
    Property Plant Equipment Net4,022,000,000USD2,858,000,000USD2,529,000,000USD2,461,000,000USD2,361,000,000USD2,360,000,000USD2,366,000,000USD2,356,000,000USD
    Goodwill11,442,000,000USD———————
    Intangible Assets2,189,000,000USD2,486,000,000USD1,725,000,000USD1,472,000,000USD1,774,000,000USD2,105,000,000USD2,918,000,000USD3,430,000,000USD
    Accounts Payable38,283,000,000USD34,713,000,000USD31,759,000,000USD29,934,000,000USD27,128,000,000USD23,700,000,000USD21,374,000,000USD21,535,000,000USD
    Short Term Debt201,000,000USD714,000,000USD551,000,000USD892,000,000USD682,000,000USD976,000,000USD10,000,000USD452,000,000USD
    Common Stock2,887,000,000USD2,956,000,000USD2,917,000,000USD2,746,000,000USD2,813,000,000USD2,806,000,000USD2,789,000,000USD2,763,000,000USD
    Retained Earnings2,009,000,000USD783,000,000USD-286,000,000USD-642,000,000USD-280,000,000USD1,205,000,000USD1,170,000,000USD5,434,000,000USD
    Accumulated Other Comprehensive Income-165,000,000USD-155,000,000USD-167,000,000USD-151,000,000USD-114,000,000USD-34,000,000USD-104,000,000USD-79,000,000USD
    Total Liab—55,756,000,000USD48,333,000,000USD46,306,000,000USD44,584,000,000USD42,659,000,000USD38,974,000,000USD34,633,000,000USD
    Other Current Liab—3,470,000,000USD3,447,000,000USD3,014,000,000USD2,842,000,000USD3,053,000,000USD2,231,000,000USD2,122,000,000USD
    Capital Stock—2,956,000,000USD2,917,000,000USD2,747,000,000USD2,813,000,000USD2,806,000,000USD2,789,000,000USD2,763,000,000USD
    Good Will—9,691,000,000USD4,725,000,000USD4,613,000,000USD5,855,000,000USD7,989,000,000USD8,357,000,000USD8,378,000,000USD
    Other Assets—956,000,000USD783,000,000USD606,000,000USD953,000,000USD951,000,000USD732,000,000USD1,006,000,000USD
    Cash—3,874,000,000USD5,133,000,000USD4,076,000,000USD4,717,000,000USD3,407,000,000USD2,771,000,000USD2,531,000,000USD
    Cash And Short Term Investments—3,874,000,000USD5,133,000,000USD4,076,000,000USD4,717,000,000USD3,407,000,000USD2,771,000,000USD2,531,000,000USD
    Net Debt—5,471,000,000USD476,000,000USD1,100,000,000USD1,088,000,000USD3,308,000,000USD4,004,000,000USD5,500,000,000USD
    Short Long Term Debt—550,000,000USD434,000,000USD792,000,000USD580,000,000USD871,000,000USD10,000,000USD452,000,000USD
    Short Long Term Debt Total—9,345,000,000USD5,609,000,000USD5,176,000,000USD5,805,000,000USD6,715,000,000USD6,775,000,000USD8,031,000,000USD
    Net Receivables—13,242,000,000USD12,084,000,000USD11,108,000,000USD10,561,000,000USD9,103,000,000USD8,264,000,000USD8,448,000,000USD
    Property Plant Equipment Gross—7,516,000,000USD6,695,000,000USD6,319,000,000USD5,883,000,000USD2,360,000,000USD2,366,000,000USD2,356,000,000USD
    Common Stock Shares Outstanding—242,000,000shares247,000,000shares262,000,000shares279,000,000shares294,000,000shares293,000,000shares301,000,000shares
    Non Current Assets Total—16,749,000,000USD10,237,000,000USD9,612,000,000USD10,943,000,000USD13,405,000,000USD14,826,000,000USD15,216,000,000USD
    Non Current Liabilities Total—16,859,000,000USD12,693,000,000USD12,566,000,000USD14,034,000,000USD15,035,000,000USD15,359,000,000USD10,524,000,000USD
    Non Current Liabilities Other—8,882,000,000USD8,035,000,000USD8,653,000,000USD9,299,000,000USD9,670,000,000USD8,594,000,000USD—
    Non Currrent Assets Other—1,700,000,000USD1,215,000,000USD1,010,000,000USD876,000,000USD883,000,000USD1,185,000,000USD1,052,000,000USD
    Net Working Capital—-2,524,000,000USD-756,000,000USD127,000,000USD2,385,000,000USD3,424,000,000USD2,325,000,000USD1,638,000,000USD
    Unclassified Non Current Assets—-942,000,000USD-740,000,000USD-550,000,000USD-876,000,000USD-883,000,000USD-732,000,000USD-1,052,000,000USD
    Unclassified Current Liabilities—-550,000,000USD-551,000,000USD-3,951,000,000USD-682,000,000USD-3,933,000,000USD—-452,000,000USD
    Unclassified Equity—-9,321,000,000USD-8,594,000,000USD-2,744,000,000USD-2,813,000,000USD-2,806,000,000USD-2,789,000,000USD-2,763,000,000USD
    Short Term Investments——200,000,000USD—————
    Deferred Long Term Liab———8,653,000,000USD9,299,000,000USD9,670,000,000USD8,594,000,000USD2,945,000,000USD
    Other Liab———8,278,000,000USD9,299,000,000USD9,670,000,000USD8,237,000,000USD2,939,000,000USD
    Current Deferred Revenue———3,059,000,000USD—2,957,000,000USD——
    Treasury Stock———-4,914,000,000USD-3,128,000,000USD-2,186,000,000USD-2,066,000,000USD-1,790,000,000USD
    Net Tangible Assets———-8,933,000,000USD-8,338,000,000USD-8,300,000,000USD-9,486,000,000USD-5,480,000,000USD
    Unclassified Non Current Liabilities———-16,927,000,000USD-18,598,000,000USD-19,340,000,000USD-16,806,000,000USD-2,939,000,000USD
    Long Term Investments———————46,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ4 20262026-06-30 · USDQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ4 20252025-06-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USD
    Net Income398,000,000USD380,000,000USD471,000,000USD454,000,000USD243,000,000USD508,000,000USD401,000,000USD417,000,000USD
    Depreciation241,000,000USD248,000,000USD234,000,000USD233,000,000USD209,000,000USD207,000,000USD192,000,000USD182,000,000USD
    Stock Based Compensation44,000,000USD129,000,000USD87,000,000USD93,000,000USD153,000,000USD31,000,000USD30,000,000USD30,000,000USD
    Operating Cash Flow1,692,000,000USD———————
    Investing Cash Flow-281,000,000USD———————
    End Cash Flow4,856,000,000USD———————
    Other Non Cash Items—215,000,000USD67,000,000USD20,000,000USD289,000,000USD-4,000,000USD16,000,000USD16,000,000USD
    Change To Account Receivables—-17,000,000USD341,000,000USD-539,000,000USD-466,000,000USD-114,000,000USD-541,000,000USD288,000,000USD
    Change To Inventory—2,094,000,000USD-3,242,000,000USD-736,000,000USD-607,000,000USD758,000,000USD-1,289,000,000USD-678,000,000USD
    Change In Working Capital—851,000,000USD-173,000,000USD173,000,000USD633,000,000USD2,175,000,000USD-1,039,000,000USD-2,292,000,000USD
    Total Cash From Operating Activities—1,823,000,000USD686,000,000USD973,000,000USD1,527,000,000USD2,917,000,000USD-400,000,000USD-1,647,000,000USD
    Capital Expenditures—-146,000,000USD-131,000,000USD-108,000,000USD-232,000,000USD-126,000,000USD-99,000,000USD-90,000,000USD
    Free Cash Flow—1,677,000,000USD555,000,000USD865,000,000USD1,295,000,000USD2,791,000,000USD-499,000,000USD-1,737,000,000USD
    Investments—27,000,000USD—-142,000,000USD-1,631,000,000USD-2,898,000,000USD-976,000,000USD-88,000,000USD
    Total Cashflows From Investing Activities—-181,000,000USD-1,980,000,000USD-142,000,000USD-1,643,000,000USD-2,898,000,000USD-976,000,000USD-88,000,000USD
    Net Borrowings—-111,000,000USD-12,000,000USD477,000,000USD789,000,000USD-11,000,000USD2,455,000,000USD-9,000,000USD
    Total Cash From Financing Activities—-483,000,000USD-519,000,000USD-110,000,000USD668,000,000USD-507,000,000USD2,331,000,000USD-540,000,000USD
    Dividends Paid—-120,000,000USD-122,000,000USD-129,000,000USD-120,000,000USD-124,000,000USD-122,000,000USD-128,000,000USD
    Sale Purchase Of Stock—-250,000,000USD-383,000,000USD-375,000,000USD765,000,000USD-375,000,000USD-15,000,000USD-375,000,000USD
    Change In Cash—1,160,000,000USD-1,816,000,000USD719,000,000USD548,000,000USD-484,000,000USD943,000,000USD-2,266,000,000USD
    Begin Period Cash Flow—2,777,000,000USD4,593,000,000USD3,874,000,000USD3,326,000,000USD3,810,000,000USD2,867,000,000USD5,133,000,000USD
    End Period Cash Flow—3,937,000,000USD2,777,000,000USD4,593,000,000USD3,874,000,000USD3,326,000,000USD3,810,000,000USD2,867,000,000USD
    Other Cashflows From Investing Activities—-20,000,000USD35,000,000USD2,000,000USD-13,000,000USD3,000,000USD-3,000,000USD2,000,000USD
    Other Cashflows From Financing Activities—-2,000,000USD-2,000,000USD-83,000,000USD-766,000,000USD3,000,000USD13,000,000USD-28,000,000USD
    Unclassified Investing Cash Flow—-42,000,000USD-1,884,000,000USD106,000,000USD233,000,000USD123,000,000USD102,000,000USD88,000,000USD
    SourceDisclosurePreliminaryLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20222022-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USD
    Depreciation956,000,000USD790,000,000USD710,000,000USD692,000,000USD692,000,000USD783,000,000USD913,000,000USD1,000,000,000USD
    Stock Based Compensation367,000,000USD244,000,000USD121,000,000USD96,000,000USD81,000,000USD89,000,000USD90,000,000USD82,000,000USD
    Deferred Income Tax91,000,000USD———————
    Change To Inventory-488,000,000USD-1,816,000,000USD1,115,000,000USD-340,000,000USD-1,071,000,000USD-1,584,000,000USD-409,000,000USD-551,000,000USD
    Change To Liabilities3,463,000,000USD——2,718,000,000USD3,428,000,000USD2,325,000,000USD-162,000,000USD1,864,000,000USD
    Change In Working Capital2,975,000,000USD-523,000,000USD1,510,000,000USD464,000,000USD1,124,000,000USD289,000,000USD6,061,000,000USD755,000,000USD
    Operating Cash Flow5,174,000,000USD———————
    Capital Expenditures-649,000,000USD-547,000,000USD-511,000,000USD-481,000,000USD-387,000,000USD-400,000,000USD-375,000,000USD-328,000,000USD
    Other Investing Activities-1,991,000,000USD———————
    Unclassified Investing Cash Flow56,000,000USD545,000,000USD493,000,000USD479,000,000USD—-25,000,000USD—-82,000,000USD
    Investing Cash Flow-2,584,000,000USD———————
    Net Debt Issuance290,000,000USD———————
    Net Common Stock Issuance-1,358,000,000USD———————
    Common Dividends Paid-491,000,000USD———————
    Other Financing Activities-11,000,000USD———————
    Unclassified Financing Cash Flow-32,000,000USD———————
    Financing Cash Flow-1,602,000,000USD———————
    Effect Of Forex Changes On Cash-6,000,000USD———————
    Change In Cash982,000,000USD-1,259,000,000USD1,057,000,000USD-674,000,000USD1,310,000,000USD636,000,000USD240,000,000USD768,000,000USD
    End Cash Flow4,856,000,000USD———————
    Net Income—1,569,000,000USD853,000,000USD262,000,000USD-932,000,000USD612,000,000USD-3,693,000,000USD1,365,000,000USD
    Other Non Cash Items—74,000,000USD672,000,000USD1,356,000,000USD2,150,000,000USD160,000,000USD-450,000,000USD-397,000,000USD
    Change To Account Receivables—-833,000,000USD-996,000,000USD-947,000,000USD-1,526,000,000USD-904,000,000USD82,000,000USD-751,000,000USD
    Total Cash From Operating Activities—2,397,000,000USD3,762,000,000USD2,839,000,000USD3,122,000,000USD2,429,000,000USD1,960,000,000USD2,722,000,000USD
    Free Cash Flow—1,850,000,000USD3,251,000,000USD2,358,000,000USD2,735,000,000USD2,029,000,000USD1,585,000,000USD2,394,000,000USD
    Investments—-5,593,000,000USD-1,849,000,000USD-454,000,000USD22,000,000USD25,000,000USD866,000,000USD-15,000,000USD
    Total Cashflows From Investing Activities—-5,605,000,000USD-1,849,000,000USD-454,000,000USD567,000,000USD-378,000,000USD493,000,000USD338,000,000USD
    Net Borrowings—3,224,000,000USD356,000,000USD-579,000,000USD-885,000,000USD-570,000,000USD-1,401,000,000USD-1,102,000,000USD
    Total Cash From Financing Activities—1,952,000,000USD-847,000,000USD-3,051,000,000USD-2,463,000,000USD-1,317,000,000USD-2,200,000,000USD-2,293,000,000USD
    Dividends Paid—-494,000,000USD-499,000,000USD-525,000,000USD-559,000,000USD-573,000,000USD-569,000,000USD-577,000,000USD
    Sale Purchase Of Stock—-765,000,000USD-750,000,000USD-2,000,000,000USD-1,000,000,000USD-200,000,000USD-350,000,000USD-600,000,000USD
    Begin Period Cash Flow—5,133,000,000USD4,076,000,000USD4,717,000,000USD3,407,000,000USD2,771,000,000USD2,531,000,000USD1,763,000,000USD
    End Period Cash Flow—3,874,000,000USD5,133,000,000USD4,043,000,000USD4,717,000,000USD3,407,000,000USD2,771,000,000USD2,531,000,000USD
    Other Cashflows From Investing Activities—-10,000,000USD18,000,000USD2,000,000USD932,000,000USD22,000,000USD2,000,000USD763,000,000USD
    Other Cashflows From Financing Activities—-13,000,000USD46,000,000USD53,000,000USD-19,000,000USD26,000,000USD120,000,000USD-14,000,000USD
    Unclassified Operating Cash Flow—243,000,000USD-104,000,000USD-31,000,000USD—496,000,000USD-961,000,000USD-83,000,000USD
    Cash And Cash Equivalents Changes———-666,000,000USD1,226,000,000USD745,000,000USD240,000,000USD768,000,000USD
    Exchange Rate Changes—————11,000,000USD-13,000,000USD1,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    Employee Healthcare Providers

    Period endPeriodValueUnitSource
    2026-06-30instant2,700employeesDisclosure

    Employees Based Outside the United States

    Period endPeriodValueUnitSource
    2026-06-30instant18,100employeesDisclosure

    Employees Covered by Collective Bargaining

    Period endPeriodValueUnitSource
    2026-06-30instant7percentDisclosure

    Employees in Other Functions

    Period endPeriodValueUnitSource
    2026-06-30instant24,200employeesDisclosure

    Full-Time Employees as a Percentage of Global Employees

    Period endPeriodValueUnitSource
    2026-06-30instant92percentDisclosure

    Global Employees

    Period endPeriodValueUnitSource
    2026-06-30instant63,900employeesDisclosure

    Operations and MSO Non-Provider Employees

    Period endPeriodValueUnitSource
    2026-06-30instant37,000employeesDisclosure

    Pharma National Logistics Centers

    Period endPeriodValueUnitSource
    2026-06-30instant1logistics_centersDisclosure

    Solaris Health Practice Locations

    Period endPeriodValueUnitSource
    2026-06-30instant250practice_locationsDisclosure

    Solaris Health Providers

    Period endPeriodValueUnitSource
    2026-06-30instant750providersDisclosure

    Solaris Health State Footprint

    Period endPeriodValueUnitSource
    2026-06-30instant14statesDisclosure

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q3 2026Quarterly · 2026-03-31GeographyInternational423,000,000USD0000721371-26-000018
    Q3 2026Quarterly · 2026-03-31GeographyUnited States60,542,000,000USD0000721371-26-000018
    Q3 2026Quarterly · 2026-03-31SegmentAll Other Segments1,706,000,000USD0000721371-26-000018
    Q3 2026Quarterly · 2026-03-31SegmentGMPD3,148,000,000USD0000721371-26-000018
    Q3 2026Quarterly · 2026-03-31SegmentPharmaceutical And Specialty Solutions56,111,000,000USD0000721371-26-000018
    Q2 2026Quarterly · 2025-12-31GeographyInternational435,000,000USD0000721371-26-000006
    Q2 2026Quarterly · 2025-12-31GeographyUnited States65,217,000,000USD0000721371-26-000006
    Q2 2026Quarterly · 2025-12-31SegmentAll Other Segments1,724,000,000USD0000721371-26-000006
    Q2 2026Quarterly · 2025-12-31SegmentGMPD3,259,000,000USD0000721371-26-000006
    Q2 2026Quarterly · 2025-12-31SegmentPharmaceutical And Specialty Solutions60,669,000,000USD0000721371-26-000006
    Q1 2026Quarterly · 2025-09-30GeographyInternational419,000,000USD0000721371-25-000130
    Q1 2026Quarterly · 2025-09-30GeographyUnited States63,611,000,000USD0000721371-25-000130
    Q1 2026Quarterly · 2025-09-30SegmentAll Other Segments1,641,000,000USD0000721371-25-000130
    Q1 2026Quarterly · 2025-09-30SegmentGMPD3,184,000,000USD0000721371-25-000130
    Q1 2026Quarterly · 2025-09-30SegmentPharmaceutical And Specialty Solutions59,205,000,000USD0000721371-25-000130
    Q4 2025Quarterly · 2025-06-30GeographyInternational434,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30GeographyUnited States59,746,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30SegmentAll Other Segments1,609,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30SegmentGMPD3,199,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-06-30SegmentPharmaceutical And Specialty Solutions55,372,000,000USDLegacy provider
    FY 2025Yearly · 2025-06-30GeographyInternational1,669,000,000USD0000721371-25-000079
    FY 2025Yearly · 2025-06-30GeographyUnited States220,993,000,000USD0000721371-25-000079
    FY 2025Yearly · 2025-06-30SegmentAll Other Segments5,382,000,000USD0000721371-25-000079
    FY 2025Yearly · 2025-06-30SegmentGMPD12,636,000,000USD0000721371-25-000079
    FY 2025Yearly · 2025-06-30SegmentPharmaceutical And Specialty Solutions204,644,000,000USD0000721371-25-000079
    Q3 2025Quarterly · 2025-03-31GeographyInternational399,000,000USD0000721371-26-000018
    Q3 2025Quarterly · 2025-03-31GeographyUnited States54,498,000,000USD0000721371-26-000018
    Q3 2025Quarterly · 2025-03-31SegmentAll Other Segments1,304,000,000USD0000721371-26-000018
    Q3 2025Quarterly · 2025-03-31SegmentGMPD3,160,000,000USD0000721371-26-000018
    Q3 2025Quarterly · 2025-03-31SegmentPharmaceutical And Specialty Solutions50,433,000,000USD0000721371-26-000018
    Q2 2025Quarterly · 2024-12-31GeographyInternational428,000,000USD0000721371-26-000006
    Q2 2025Quarterly · 2024-12-31GeographyUnited States54,858,000,000USD0000721371-26-000006
    Q2 2025Quarterly · 2024-12-31SegmentAll Other Segments1,283,000,000USD0000721371-26-000006
    Q2 2025Quarterly · 2024-12-31SegmentGMPD3,154,000,000USD0000721371-26-000006
    Q2 2025Quarterly · 2024-12-31SegmentPharmaceutical And Specialty Solutions50,849,000,000USD0000721371-26-000006
    Q1 2025Quarterly · 2024-09-30GeographyInternational408,000,000USD0000721371-25-000130
    Q1 2025Quarterly · 2024-09-30GeographyUnited States51,891,000,000USD0000721371-25-000130
    Q1 2025Quarterly · 2024-09-30SegmentAll Other Segments1,186,000,000USD0000721371-25-000130
    Q1 2025Quarterly · 2024-09-30SegmentGMPD3,123,000,000USD0000721371-25-000130
    Q1 2025Quarterly · 2024-09-30SegmentPharmaceutical And Specialty Solutions47,990,000,000USD0000721371-25-000130
    Q4 2024Quarterly · 2024-06-30GeographyInternational440,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-06-30GeographyUnited States59,448,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-06-30SegmentAll Other Segments1,172,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-06-30SegmentGMPD3,109,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-06-30SegmentPharmaceutical And Specialty Solutions55,607,000,000USDLegacy provider
    FY 2024Yearly · 2024-06-30GeographyInternational1,681,000,000USD0000721371-25-000079
    FY 2024Yearly · 2024-06-30GeographyUnited States225,231,000,000USD0000721371-25-000079
    FY 2024Yearly · 2024-06-30SegmentAll Other Segments4,512,000,000USD0000721371-25-000079
    FY 2024Yearly · 2024-06-30SegmentGMPD12,381,000,000USD0000721371-25-000079
    FY 2024Yearly · 2024-06-30SegmentPharmaceutical And Specialty Solutions210,019,000,000USD0000721371-25-000079
    FY 2023Yearly · 2023-06-30GeographyInternational1,617,000,000USD0000721371-25-000079
    FY 2023Yearly · 2023-06-30GeographyUnited States203,440,000,000USD0000721371-25-000079
    FY 2023Yearly · 2023-06-30SegmentAll Other Segments4,021,000,000USD0000721371-25-000079
    FY 2023Yearly · 2023-06-30SegmentGMPD12,222,000,000USD0000721371-25-000079
    FY 2023Yearly · 2023-06-30SegmentPharmaceutical And Specialty Solutions188,814,000,000USD0000721371-25-000079
    FY 2022Yearly · 2022-06-30GeographyInternational1,923,000,000USD0000721371-24-000056
    FY 2022Yearly · 2022-06-30GeographyUnited States179,471,000,000USD0000721371-24-000056
    FY 2022Yearly · 2022-06-30SegmentAll Other Segments3,518,000,000USD0000721371-24-000056
    FY 2022Yearly · 2022-06-30SegmentGMPD13,280,000,000USD0000721371-24-000056
    FY 2022Yearly · 2022-06-30SegmentPharmaceutical And Specialty Solutions164,596,000,000USD0000721371-24-000056
    FY 2021Yearly · 2021-06-30GeographyInternational4,727,000,000USD0000721371-23-000060
    FY 2021Yearly · 2021-06-30GeographyUnited States157,756,000,000USD0000721371-23-000060
    FY 2021Yearly · 2021-06-30SegmentMedical Member16,687,000,000USD0000721371-23-000060
    FY 2021Yearly · 2021-06-30SegmentPharmaceutical145,796,000,000USD0000721371-23-000060
    FY 2020Yearly · 2020-06-30GeographyInternational4,232,000,000USD0000721371-22-000058
    FY 2020Yearly · 2020-06-30GeographyUnited States148,707,000,000USD0000721371-22-000058
    FY 2020Yearly · 2020-06-30SegmentMedical Member15,444,000,000USD0000721371-22-000058
    FY 2020Yearly · 2020-06-30SegmentPharmaceutical137,495,000,000USD0000721371-22-000058
    FY 2019Yearly · 2019-06-30GeographyInternational4,071,000,000USD0000721371-21-000080
    FY 2019Yearly · 2019-06-30GeographyUnited States141,479,000,000USD0000721371-21-000080
    FY 2019Yearly · 2019-06-30SegmentMedical Member15,633,000,000USD0000721371-21-000080
    FY 2019Yearly · 2019-06-30SegmentPharmaceutical129,917,000,000USD0000721371-21-000080
    FY 2018Yearly · 2018-06-30GeographyInternational4,283,000,000USD0000721371-20-000089
    FY 2018Yearly · 2018-06-30GeographyUnited States132,539,000,000USD0000721371-20-000089
    FY 2018Yearly · 2018-06-30SegmentMedical15,581,000,000USD0000721371-20-000089
    FY 2018Yearly · 2018-06-30SegmentPharmaceutical121,241,000,000USD0000721371-20-000089

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.